Overview

Cat's claw (Uncaria tomentosa) is a large woody vine belonging to the Rubiaceae family, native to the tropical rainforests of Central and South America, particularly the Amazon basin of Peru. The common name derives from the hook-like thorns along the vine that resemble a cat's claws. It has been used for centuries in traditional Peruvian medicine by indigenous Asháninka people for the treatment of inflammatory conditions, infections, and gastrointestinal disorders.

The primary bioactive constituents of cat's claw include pentacyclic and tetracyclic oxindole alkaloids, with the pentacyclic forms (including isopteropodine, pteropodine, and mitraphylline) considered the most therapeutically relevant. These alkaloids have demonstrated immunomodulatory effects, including enhancement of phagocytosis and modulation of NF-kB signaling. Additional bioactive compounds include quinovic acid glycosides, polyphenols, and proanthocyanidins, which contribute to the plant's antioxidant and anti-inflammatory activities.

Clinical research has evaluated cat's claw for osteoarthritis, rheumatoid arthritis, and immune support. A notable randomized controlled trial found that a specific extract (Uncaria guianensis) reduced pain in knee osteoarthritis compared to placebo. DNA repair enhancement has also been documented, with studies showing reduced DNA damage in human subjects following supplementation. Cat's claw is available commercially as capsules, teas, and liquid extracts, though standardization varies significantly between products due to the complexity of its phytochemical profile.

Mechanism of Action

Oxindole & Pentacyclic Alkaloid Pharmacology

Cat's claw (Uncaria tomentosa) contains two chemotypes distinguished by their alkaloid profiles: pentacyclic oxindole alkaloids (POAs) — mitraphylline, isomitraphylline, pteropodine, isopteropodine, speciophylline, uncarine F — and tetracyclic oxindole alkaloids (TOAs) — rhynchophylline, isorhynchophylline. POAs are the primary immunomodulatory constituents, enhancing phagocytosis by macrophages and neutrophils, and increasing IL-1 and IL-6 production at low concentrations. TOAs antagonize the immunostimulatory effects of POAs, making chemotype selection critical for standardized extracts (PMID: 15862904).

NF-kB Inhibition & Anti-Inflammatory Cascade

The quinovic acid glycosides and oxindole alkaloids in cat's claw potently inhibit NF-kB activation by blocking IKKbeta-mediated phosphorylation of IkBalpha. This suppresses transcription of COX-2, iNOS, TNF-alpha, and IL-1beta. Cat's claw extract also inhibits TNF-alpha production directly by stabilizing TNF-alpha mRNA degradation through AU-rich element-mediated decay. The anti-inflammatory potency is comparable to dexamethasone in some cell-based assays, without glucocorticoid receptor involvement (PMID: 11746047).

DNA Repair Enhancement

A distinguishing property of cat's claw is its ability to enhance nucleotide excision repair (NER) and base excision repair (BER) pathways. Aqueous extracts from the inner bark upregulate expression of XRCC1, OGG1, and ERCC1 repair enzymes, accelerating the removal of oxidative DNA lesions (8-oxoguanine) and UV-induced pyrimidine dimers. Human studies demonstrated significant reductions in DNA damage markers after 8 weeks of supplementation with a standardized C-Med-100 extract (PMID: 11453710).

Immune Cell Proliferation & Apoptosis Regulation

Pteropodine and isopteropodine bind to 5-HT2A serotonin receptors on lymphocytes, enhancing T-cell and B-cell proliferation. Cat's claw alkaloids also modulate Bcl-2/Bax ratios in leukemic and solid tumor cell lines, promoting apoptosis in transformed cells while protecting normal lymphocytes (PMID: 17097234).

Reconstitution Calculator

Research

Safety Profile

Safety Profile: Cat's Claw (Uncaria tomentosa)

Common Side Effects

• Gastrointestinal symptoms (nausea, diarrhea, stomach discomfort) in ~10-15% of users
• Headache
• Dizziness
• Hypotension (low blood pressure)
• Skin rash

Serious Adverse Effects

• Acute kidney injury: Rare case reports of interstitial nephritis associated with cat's claw use
• Hemorrhagic stroke: Theoretical risk due to antiplatelet/anticoagulant properties, especially with concurrent blood thinners
• Autoimmune flares: Immunostimulatory properties may exacerbate autoimmune conditions
• Hepatotoxicity: Isolated case reports of liver injury
• Severe allergic reactions: Anaphylaxis reported rarely; cross-reactivity possible with Rubiaceae family plants

Contraindications

• Autoimmune diseases (MS, lupus, rheumatoid arthritis) -- immunostimulant effects may trigger flares
• Pre-surgical patients (discontinue 2+ weeks before surgery due to anticoagulant effects)
• Active bleeding disorders
• Organ transplant recipients on immunosuppressive therapy
• Known allergy to Rubiaceae family plants
• Leukemia (theoretical concern about stimulating abnormal white blood cells)

Drug Interactions

• Immunosuppressants (cyclosporine, tacrolimus, mycophenolate): May counteract immunosuppressive effects; organ rejection risk
• Anticoagulants/Antiplatelets (warfarin, clopidogrel, aspirin): Additive bleeding risk; cat's claw inhibits platelet aggregation
• Antihypertensives: Additive hypotensive effects; monitor blood pressure
• CYP3A4 substrates: Cat's claw inhibits CYP3A4 in vitro; may increase levels of statins, calcium channel blockers, HIV protease inhibitors
• Antiretroviral drugs (protease inhibitors): CYP3A4 inhibition may alter drug levels significantly
• Hormonal contraceptives: Theoretical reduced efficacy via CYP interactions

Population-Specific Considerations

• Pregnancy: Contraindicated; traditional use as contraceptive/abortifacient. Animal data suggests anti-implantation effects
• Lactation: Insufficient safety data; avoid during breastfeeding
• Pediatric: Not recommended for children under 12; no established safety data
• Elderly: Use with caution due to hypotensive effects and polypharmacy interaction potential
• Renal impairment: Case reports of nephritis; monitor kidney function
• Hepatic impairment: Use cautiously; potential hepatotoxic effects

Pharmacokinetic Profile